Frequently Asked Questions
Where is Telomir Pharmaceuticals, Inc. corporate headquarters?
Our corporate headquarters is located at 100 SE 2nd St., Suite 2000 #1009, Miami, FL 33131.
What does Telomir Pharmaceuticals, Inc. do?
Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) is a clinical-stage biotechnology company developing Telomir-Zn, a novel oral epigenetic therapy for the treatment of cancer. The Company's lead program is focused on advanced triple-negative breast cancer (TNBC), an aggressive form of breast cancer with significant unmet medical need.
Telomir-Zn is designed to modulate intracellular metal homeostasis, influencing iron-dependent epigenetic pathways involved in tumor growth and treatment resistance. The Company believes this differentiated mechanism has the potential to restore normal gene regulation and provide a novel therapeutic approach for patients with TNBC.
Telomir has received FDA IND clearance to initiate a Phase 1/2 clinical trial evaluating Telomir-Zn in patients with advanced TNBC.
Telomir-Zn is designed to modulate intracellular metal homeostasis, influencing iron-dependent epigenetic pathways involved in tumor growth and treatment resistance. The Company believes this differentiated mechanism has the potential to restore normal gene regulation and provide a novel therapeutic approach for patients with TNBC.
Telomir has received FDA IND clearance to initiate a Phase 1/2 clinical trial evaluating Telomir-Zn in patients with advanced TNBC.
When was Telomir Pharmaceuticals, Inc. founded?
The Company was founded in August 2021.
On which exchange is Telomir Pharmaceuticals, Inc. listed, what is the ticker symbol and when did it go public?
The Company is listed on Nasdaq and trade under the symbol “TELO.” Telomir went public on February 9, 2024.
Where is Telomir Pharmaceuticals, Inc. located?
Telomir Pharmaceuticals, Inc.
100 SE 2nd St., Suite 2000 #1009
Miami, FL 33131
Tel.: (786) 396-6723
[email protected]
100 SE 2nd St., Suite 2000 #1009
Miami, FL 33131
Tel.: (786) 396-6723
[email protected]
When is Telomir Pharmaceuticals, Inc. fiscal year end?
Our fiscal year end is December 31.
Who is Telomir Pharmaceuticals, Inc. transfer agent?
Our transfer agent is Equiniti. They can be reached at 800-401-1957 from the US or 800-468-9716 from Canada or the US Virgin Islands. All callers from all other countries can find the appropriate number for their country in the International Access Codes page.
Who is Telomir Pharmaceuticals, Inc. outside legal counsel?
Our outside legal counsel is Cozen O'Connor.
Who is Telomir Pharmaceuticals, Inc. independent auditor?
Our independent auditor is Salberg & Company, P.A.
Where can I find copies of Telomir Pharmaceuticals, Inc. financial documents, including annual reports (Form-10K) and quarterly reports (Form 10-Q)?
You can find our SEC filings, including our annual and quarterly reports, at ir.telomirpharma.com or sec.gov.
Whom should I contact regarding investor inquiries?
You may send your inquiries to [email protected]